News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
Thursday, October 03, 2024Arcus Biosciences Inc a clinicalstage global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer today announced a clinical trial collaboration agreement with AstraZeneca to evalua...
QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
Tuesday, October 01, 2024QIAGEN NV announced the launch of the QIAcuityDx Digital PCR System a pivotal addition to its digital PCR portfolio now expanding into clinical diagnostics The instrument and accessories are k exempt in the US and IVDRcertified for diagnostic use
COUR Pharmaceuticals Announces Positive Top-line Results from Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
Tuesday, October 01, 2024COUR Pharmaceuticals a clinicalstage biotechnology company developing rstinclass diseasemodifying therapies designed to induce antigenspecic tolerance for immunemediated diseases today announced positive day data from its Phase a study evaluating CNP
Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity
Tuesday, October 01, 2024Thermo Fisher Scientific Inc today launched the Thermo Scientific iCAP MX Series ICPMS to simplify trace element analysis with inductively coupled plasma mass spectrometry ICPMS The launch includes a new single quadrupole Thermo Scientific iCAP MSX I...
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
Monday, September 30, 2024Boehringer Ingelheim has entered a partnership with the NCD Alliance a network dedicated to shaping a world in which everyone can live a healthy and productive life free from the preventable suffering stigma disability and death caused by noncommunic...
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
Monday, September 30, 2024Altamira Therapeutics Ltd announced that its associate company Altamira Medica Ltd obtained extended ISO certification for its quality management system including henceforth also production activities With this extension the quality management syste...
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
Friday, September 27, 2024QIAGEN announced that its QIAstatDx syndromic testing systems and associated assays have received CEmarking under the European Unions new InVitro Diagnostic Medical Devices Regulation IVDR This certification includes the widelyused QIAstatDx Analyzer
Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome
Friday, September 27, 2024Minovia Therapeutics Ltd a clinical stage biopharmaceutical company advancing mitochondrial cell therapies for primary and secondary mitochondrial diseases today announced that the US Food and Drug Administration FDA has cleared its Investigational N...
Boehringer Ingelheim expands cancer research at its Vienna site
Thursday, September 26, 2024Boehringer Ingelheim is one of the worlds leading researchoriented pharmaceutical companies The clinical pipeline is constantly being further developed and Boehringer Ingelheim expects new approvals also in oncology in the coming years
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
Thursday, September 26, 2024Orion Corporation and Aitia an AIenabled biotechnology company and the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs announced today that the companies have entered into agreement to create
